IGFLR3
IGF-1 LR3
No registered human study names IGF-1 LR3 as an intervention. ClinicalTrials.gov holds no trial of it, so there is no trial evidence to read — a fact about the public record rather than proof the compound does nothing. No FDA-approved product contains IGF-1 LR3. 10 papers naming it were published in the last ten years.
Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Counts include only trials whose registered intervention names IGF-1 LR3; the registry search is fuzzy, so every match is re-checked. None of this says whether IGF-1 LR3 works or is safe.
FDA status
Research only
Human studies
0
Furthest phase
—
Papers, 10 yr
10
Readership
2,390
monthly average, Feb–Jul 2026
Tracking since 2026-07-29 · About this data
What has actually been tested in humans
No registered human study
0
Registered human studies
None
No FDA-approved product contains it
No study of IGF-1 LR3 in humans is registered on ClinicalTrials.gov. That is a fact about the public record, not a statement that the compound does nothing — but it does mean there is no trial evidence to read, and anyone telling you otherwise should be asked for the registration number. The grade is mechanical: it is computed from the registry and the FDA record alone, and it grades how much is known, never whether a compound is good or safe. Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Check the query.
What IGF-1 LR3 is, and what it has been studied for
IGF-1 LR3 is tracked here.
No registered trial names IGF-1 LR3 as an intervention, so there is no condition it has been formally studied in. It does have a literature: 10 indexed papers name it in the last ten years. That work is laboratory and animal research, and a paper is not a trial.
Is anyone studying IGF-1 LR3?
Papers published each year that name IGF-1 LR3 in the title or abstract, with the clinical trials that started in the same year marked beneath. Ten calendar years.
| Year | Publications | Trials started | Complete year |
|---|---|---|---|
| 2017 | 0 | 0 | Yes |
| 2018 | 0 | 0 | Yes |
| 2019 | 0 | 0 | Yes |
| 2020 | 1 | 0 | Yes |
| 2021 | 2 | 0 | Yes |
| 2022 | 1 | 0 | Yes |
| 2023 | 2 | 0 | Yes |
| 2024 | 2 | 0 | Yes |
| 2025 | 3 | 0 | Yes |
| 2026 | 1 | 0 | No |
10 papers between 2017 and 2026. A paper counts when “IGF-1 LR3” appears in its title or abstract — phrase-matched, so a paper mentioning the words separately is not counted. The total is a single query over the whole window, which is why it does not equal the bars added together: PubMed files a paper under both its electronic and its print publication date, so one paper can appear in two years. Publication volume measures scientific attention, not whether a compound works: a well-studied compound can be well-studied and ineffective. Sources: PubMed and ClinicalTrials.gov · collected 2026-08-02.
Published research on IGF-1 LR3
10 indexed papers name IGF-1 LR3 in their title or abstract. These are the 8 PubMed ranks most relevant. Listing a paper is not a judgement about it, and none of these is summarised here — follow the link and read what it says.
- Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris
- IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep
- Attenuated glucose-stimulated insulin secretion during an acute IGF-1 LR3 infusion into fetal sheep does not persist in isolated islets
- Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration
- Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep
- IGF-1 infusion to fetal sheep increases organ growth but not by stimulating nutrient transfer to the fetus
- Reduced glucose-stimulated insulin secretion following a 1-wk IGF-1 infusion in late gestation fetal sheep is due to an intrinsic islet defect
- Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes
Collected 2026-08-02from PubMed, phrase-matched on “IGF-1 LR3” in title and abstract. Run the same search.
Reading on this compound
All articles →PepRack articles that reference this compound. This is not a news feed — we syndicate nothing and publish no datelines.
Vendor listings are not affiliate links and PepRack earns nothing from them. A listing records a price we observed on a date. It is not a recommendation of a product, dose, or treatment, and PepRack does not verify what any vendor ships.